Formation Bio signs deal for TYK2 drug from China’s Lynknews2025-12-10T12:00:15+00:00December 10th, 2025|Endpoints News|
Novartis to partner with AI-focused Relation on atopic diseasesnews2025-12-09T16:19:37+00:00December 9th, 2025|Endpoints News|
“Heavy AI” is taking over biopharma | Signal Pulse Reportnews2025-12-01T13:53:30+00:00December 1st, 2025|Endpoints News|
Generate:Biomedicines to start Phase 3 studies for TSLP antibodynews2025-12-01T11:00:16+00:00December 1st, 2025|Endpoints News|
AI biotech Profluent closes $106M raise with Jeff Bezos’ supportnews2025-11-19T15:15:30+00:00November 19th, 2025|Endpoints News|
Nabla Bio announces AI antibody model update in JAM-2news2025-11-19T10:00:53+00:00November 19th, 2025|Endpoints News|
Boston biotech AI Proteins raises $42M Series A round for miniproteinsnews2025-11-18T12:00:31+00:00November 18th, 2025|Endpoints News|
Terray Therapeutics unveils AI platform EMMI, selection modelnews2025-11-17T16:00:31+00:00November 17th, 2025|Endpoints News|
Mental health companies, once wary of AI, are building chatbotsnews2025-11-13T14:00:56+00:00November 13th, 2025|Endpoints News|
AI biotech Iambic raises $100M from ARK, Regeneronnews2025-11-10T12:00:53+00:00November 10th, 2025|Endpoints News|
